Mrs. Sherry Lynn Chriswell, LPN Licensed Practical Nurse Medicare: Not Enrolled in Medicare Practice Location: 59 Hospital Rd, Newnan, GA 30263 Phone: 404-771-8788 |
Maureen Carney, LPN Licensed Practical Nurse Medicare: Not Enrolled in Medicare Practice Location: 59 Hospital Rd, Newnan, GA 30263 Phone: 678-854-6394 |
Carles Stinson, LPN Licensed Practical Nurse Medicare: Not Enrolled in Medicare Practice Location: 26 Saint Clair St, Newnan, GA 30263 Phone: 770-755-7460 Fax: 770-755-7461 |
Lisa D Watson, LPN Licensed Practical Nurse Medicare: Not Enrolled in Medicare Practice Location: 59 Hospital Rd, Newnan, GA 30263 Phone: 678-423-4610 Fax: 770-254-7419 |
Teresa Lord Schoenbeck, LPN Licensed Practical Nurse Medicare: Not Enrolled in Medicare Practice Location: 52 Perry St, Newnan, GA 30263 Phone: 678-854-2100 |
Sheri Raymond, LPN Licensed Practical Nurse Medicare: Not Enrolled in Medicare Practice Location: 59 Hospital Rd, Newnan, GA 30263 Phone: 678-423-4610 |
Tracy Lynn Littlepage, Licensed Practical Nurse Medicare: Not Enrolled in Medicare Practice Location: 59 Hospital Rd, Newnan, GA 30263 Phone: 678-423-4610 Fax: 770-254-7419 |
Jessica Thompson, LPN Licensed Practical Nurse Medicare: Not Enrolled in Medicare Practice Location: 59 Hospital Rd, Newnan, GA 30263 Phone: 678-423-4610 Fax: 770-254-7419 |
News Archive
Asparity Decision Solutions, a leading provider of decision support and data solutions in health care and employee benefits, reports that 50,000 federal employees used PlanSmartChoice during the 2010 federal open season to become better health care consumers.
Peter Orszag, director of the Office of Management and Budget, will step down from his post in July, "according to two knowledgeable administration officials," The Wall Street Journal reports.
The U.S. Food and Drug Administration today approved Azedra (iobenguane I 131) injection for intravenous use for the treatment of adults and adolescents age 12 and older with rare tumors of the adrenal gland (pheochromocytoma or paraganglioma) that cannot be surgically removed (unresectable), have spread beyond the original tumor site and require systemic anticancer therapy.
AVEO Pharmaceuticals, Inc., a biopharmaceutical company focused on discovering, developing and commercializing cancer therapeutics, today provided an update on recent research and development (R&D) and business accomplishments, and announced financial results for the quarter ended June 30, 2010.
A new potential target to slow breast cancer tumor progression and metastasis has been identified by a team of researchers led by Dr. Richard Kremer from the Research Institute of the McGill University Health Centre.
› Verified 9 days ago